Specialty pharmacy may be one of the most rapidly rising costs in all of healthcare, but these costs are shouldered by a small percentage of patients. As such, it is essential that new innovative payment models be developed for these new products, said Steve Miller, MD, senior vice president and chief medical officer of Express Scripts.
Specialty pharmacy may be one of the most rapidly rising costs in all of healthcare, but these costs are shouldered by a small percentage of patients. As such, it is essential that new innovative payment models be developed for these new products, said Steve Miller, MD, senior vice president and chief medical officer of Express Scripts.
Transcript (slightly modified)
What are the opportunities and challenges facing specialty pharmacy over the next few years?
Yeah, so specialty is actually one of the most rapidly rising costs in all of healthcare. Right now you have about 1% to 2% of patients spending about 30% of the pharmacy dollars; by 2018 that grows, that 1% to 2% of patients will be spending 50% of the pharmacy dollars. And so it’s an enormous strain for all, both patients but also plan sponsors. So specialty pharmacy is going to be central to pharmacy for the next several years, and it really is the hot topic.
How will specialty pharmacy be impacted by innovations in our healthcare system?
There are several ways to think about that. One is innovations in new technologies and so when you look at the drug pipeline, almost the entire pipeline is devoted to specialty drugs. And so you’re going to see more and more drugs coming into the marketplace, but almost all of them are going to be specialty drugs. The second way you got to think about innovation is how we’re going to pay for these drugs. Historically, you had cancer chemotherapy at $10,000; for chemotherapy it’s now over $100,000. You have gene therapy that’s going to be entering the market in the next several years and that’s going to be over a million dollars, and so not only are we going to have innovative new products but we’re going to have to come up with innovative new models to pay for those products.
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More